Feb 3 (Reuters) - AstraZeneca said on Tuesday the U.S. health regulator has rejected its application for a self-injectable ...
Anglo-Swedish drumaker AstraZeneca said on Tuesday that the U.S. Food and Drug Administration has declined to approve its ...
By Padmanabhan Ananthan Feb 2 (Reuters) - Aquestive Therapeutics said on Monday the U.S. FDA has declined to approve its oral ...
By Ahmed Aboulenein WASHINGTON, Feb 1 (Reuters) - The U.S. Food and Drug Administration on Sunday began accepting requests to ...
By Kamal Choudhury Jan 30 (Reuters) - Shares of Corcept Therapeutics fell 16% on Friday after a corrected "complete response ...
Orphan Drug Designation applies to approximately 50,000 Patients who predominantly suffer from severe chronic pain due ...
A year after the FDA rejected its drug for kidney dialysis patients, Unicycive Therapeutics could win approval ...
Annovis is also seeking fresh capital while working to advance trials for both Alzheimer's and Parkinson's disease drugs.
Otsuka Pharmaceutical announced that the FDA is reviewing investigational centanafadine -- a potential first-in-class ...
The company is working with the U.S. regulator to move forward with an updated application, adding a decision is expected in ...
THE Food and Drug Administration (FDA) warned the public against the presence of a counterfeit version of an anti-rabies ...
The FDA laid out the qualifications a site would need to qualify for PreCheck on a webpage where companies can also submit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results